PAECYLOMYCOTIC ATYPICAL MYOCARDITIS AND ITS TREATMENT IN CHILDREN

• Main Authors: A. V. Strelyaeva, E. R. Gasparyan, I. V. Teres, S. S. Zuev, A. T. Sagieva, Kh. N. Shadyeva, N. B. Lazareva, V. M. Sadykov, T. A. Shcheglova
• Format: Article
• Language: Russian
• Published: «FIRMA «SILICEA» LLC 2011-10-01
• Series: Российский кардиологический журнал
• Subjects: atypical myocarditis; paecilomycosis; pain syndrome; latrodectus mactans; diflucan; polyoxydonium
• Online Access: https://russjcardiol.elpub.ru/jour/article/view/1145

In experimental studies using radioactive isotopes in chicken, it has been clearly demonstrated that paecilomycosis diagnostics, based on the detection of mycotic spherules in the blood, is a valid and clinically feasible method. For the first time, paecilomycotic atypical myocarditis (PAM) in children was described. This disease is characterised by anemic and pain syndromes: pain is localized in the arms, and then involves chest, abdominal area, and spinal areas. Modern analgetic agents – movalis, sirdalud, clopheline, and nimesil – are not effective in children with PAM and pain syndrome. The complex treatment included a homeopathic medication Latrodectus mactans C6, as well as diflucan, polyoxydonium, antibiotics, and ferrum lek. The use of Latrodectus mactans C6 was associated with the pain syndrome regression. In 5 animal species, the authors demonstrated that Latrodectus mactans C6 did not have any adverse or toxic effects. The statistical significance of the results was confirmed by p values of ≤0,01–0,05 in the Student test.